- Teladoc Health schedules annual stockholders meeting as virtual session on May 21, 2026.
- Ballot includes election of nine director nominees for one-year terms.
- Stockholders will also vote on advisory approval of executive compensation.
- Separate proposal seeks ratification of Ernst & Young as independent auditor for fiscal 2026.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Teladoc Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001477449-26-000020), on April 07, 2026, and is solely responsible for the information contained therein.
Comments